skip to main content

Apixaban INR query — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModeratePatient Counselling and Pharmaceutical CareApixaban INR queryGPhC CRA

A patient newly prescribed apixaban asks whether they need routine INR tests like someone on warfarin. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Routine INR monitoring is not used, but adherence, renal review and bleeding vigilance remain important

DOACs do not require INR monitoring but still require safety counselling. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.

Reference: BNF; NICE CKS